YEW Grove REIT PLC Q&A with CEO Jonathan Laredo (LON:YEW)
11 September 2019
Cross Country Healthcare, Inc. (NASDAQ: CCRN), a prominent player in the healthcare sector, primarily operates within the medical care facilities industry in the United States. With a market capitalization of..
REGENXBIO Inc. (NASDAQ: RGNX) stands out as a compelling opportunity within the biotechnology sector, offering a remarkable potential upside of 166.97%. With a market capitalization of $537.85 million, this clinical-stage..
For investors seeking opportunities in the high-stakes world of biotechnology, Precigen, Inc. (NASDAQ: PGEN) presents an intriguing proposition. With a current market capitalization of $1.48 billion, this U.S.-based biopharmaceutical company..
Embecta Corp. (NASDAQ: EMBC) presents an intriguing opportunity for investors, particularly those with a keen eye for high-yield dividends and significant potential upside. Operating in the healthcare sector, specifically within..
Treace Medical Concepts, Inc. (NASDAQ: TMCI), a pioneering entity in the healthcare sector, is drawing investor attention with its innovative approach to medical devices, particularly in the field of bunion..
EyePoint, Inc. (EYPT), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating serious retinal diseases. With a market capitalization of $1.12 billion, the..
Auna SA (AUNA), a key player in the healthcare sector, is garnering significant attention from investors due to its substantial upside potential and strategic positioning in emerging markets. Headquartered in..
COMPASS Pathways Plc (NASDAQ: CMPS) has been capturing investor attention with its pioneering approach in the mental health sector. Based in London, the company is making strides with its psilocybin..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is catching the attention of investors with its promising potential upside of 47.87%, despite its current challenges. As a clinical-stage biotechnology company, Dianthus is pioneering..
Inventiva S.A. (IVA), a French biopharmaceutical innovator, presents a compelling investment opportunity within the healthcare sector, specifically in the biotechnology industry. Known for its development of oral small molecule therapies..
Investors with a keen eye on the biotechnology sector might find Theravance Biopharma, Inc. (NASDAQ: TBPH) an intriguing prospect. As a company focused on developing and commercializing innovative medicines, Theravance..
Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a pioneering company in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 77.77%. As a clinical-stage biotech firm, Taysha..
Tilray Brands, Inc. (NASDAQ: TLRY), a major player in the healthcare sector, specifically in the drug manufacturing industry, is navigating a complex landscape with its diversified portfolio that spans medical..
InnovAge Holding Corp. (NASDAQ: INNV), a healthcare company specializing in senior care services, presents a fascinating case for investors navigating the medical care facilities industry. With a market capitalization of..
Investors looking for opportunities in the biotechnology sector may find Tectonic Therapeutic, Inc. (NASDAQ: TECX) particularly compelling. Despite the current market volatility, Tectonic’s focus on innovative therapeutic proteins aimed at..
Neuropace, Inc. (NASDAQ: NPCE), a trailblazer in the medical devices sector, is capturing investor attention with its impressive 23.9% revenue growth and unanimous buy ratings from analysts. As a pivotal..
Ardelyx, Inc. (NASDAQ: ARDX) stands out as a compelling opportunity in the biotechnology sector, capturing investor attention with a remarkable potential upside of 134%. This potential is underscored by strong..
Investors eyeing the biotechnology sector may find Arvinas, Inc. (ARVN) an intriguing prospect, particularly given the potential upside of nearly 48% as reflected by the current average analyst target price...
Pharvaris N.V. (PHVS), a biopharmaceutical company rooted in Switzerland’s burgeoning biotech sector, is drawing attention from investors due to its promising pipeline of therapies targeting rare diseases, particularly those linked..
Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, has garnered attention for its innovative medical device solutions, particularly in the fields of digestive health and pain..
